Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

Similar articles for PubMed (Select 19845975)

1.

The feasibility of harmonizing health technology assessments across jurisdictions: a case study of drug eluting stents.

Trueman P, Hurry M, Bending M, Hutton J.

Int J Technol Assess Health Care. 2009 Oct;25(4):455-62. doi: 10.1017/S0266462309990389.

PMID:
19845975
2.

HTA and its legal issues: a framework for identifying legal issues in health technology assessment.

Widrig D, Tag B.

Int J Technol Assess Health Care. 2014 Dec;30(6):587-94. doi: 10.1017/S0266462314000683.

PMID:
25816824
3.

Collaborative models for the joint production of core health technology assessments: negative and positive aspects for the joint work of different European agencies.

Lo Scalzo A, Vicari N, Corio M, Perrini MR, Jefferson T, Gillespie F, Cerbo M.

Int J Technol Assess Health Care. 2014 Nov;30(5):536-43. doi: 10.1017/S026646231400066X.

PMID:
25747564
4.

Comparing the hta core model with a national health technology assessment report.

Pasternack I, de Groot I, Kleijnen S, Polman P.

Int J Technol Assess Health Care. 2014 Nov;30(5):530-5. doi: 10.1017/S0266462314000610.

PMID:
25747563
5.

Developing the HTA core model for the online environment.

Lampe K, Pasternack I, Saarekas O, Raustia L, Cleemput I, Corio M, Endel G, Frønsdal K, Imaz I, Kleijnen S, Kristensen F, Rüther A, Werkö S, Cerbo M.

Int J Technol Assess Health Care. 2014 Nov;30(5):478-87. doi: 10.1017/S0266462314000646.

PMID:
25747556
6.

What's in a name? Developing definitions for common health technology assessment product types of the International Network of Agencies for Health Technology Assessment (inahta).

Merlin T, Tamblyn D, Ellery B; INAHTA Quality Assurance Group.

Int J Technol Assess Health Care. 2014 Oct;30(4):430-7. doi: 10.1017/S0266462314000543. Epub 2014 Nov 14.

PMID:
25397872
7.

Measurement of health outcomes.

Thavorncharoensap M.

J Med Assoc Thai. 2014 May;97 Suppl 5:S27-32.

PMID:
24964696
8.

Value of databases other than medline for rapid health technology assessments.

Lorenzetti DL, Topfer LA, Dennett L, Clement F.

Int J Technol Assess Health Care. 2014 Apr;30(2):173-8. doi: 10.1017/S0266462314000166. Epub 2014 Apr 28.

PMID:
24774535
9.

Surrogate outcomes: experiences at the Common Drug Review.

Rocchi A, Khoudigian S, Hopkins R, Goeree R.

Cost Eff Resour Alloc. 2013 Dec 17;11(1):31. doi: 10.1186/1478-7547-11-31.

10.

Minor ailments across Canadian jurisdictions.

Noseworthy J.

Can Pharm J (Ott). 2013 Sep;146(5):296-8. doi: 10.1177/1715163513502297. No abstract available.

11.

Methods of international health technology assessment agencies for economic evaluations--a comparative analysis.

Mathes T, Jacobs E, Morfeld JC, Pieper D.

BMC Health Serv Res. 2013 Sep 30;13:371. doi: 10.1186/1472-6963-13-371.

12.

Collaboration in health technology assessment (EUnetHTA joint action, 2010-2012): four case studies.

Huić M, Nachtnebel A, Zechmeister I, Pasternak I, Wild C.

Int J Technol Assess Health Care. 2013 Jul;29(3):323-30. doi: 10.1017/S0266462313000305. Epub 2013 Jun 12.

PMID:
23759333
13.

Assessing the international use of health technology assessments: exploring the merits of different methods when applied to the National Institute of Health Research Health Technology Assessment (NIHR HTA) programme.

Wright D, Milne R, Price A, Tose N.

Int J Technol Assess Health Care. 2013 Apr;29(2):192-7. doi: 10.1017/S026646231300010X. Epub 2013 Apr 3.

PMID:
23552058
14.

Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions.

Spinner DS, Birt J, Walter JW, Bowman L, Mauskopf J, Drummond MF, Copley-Merriman C.

Clinicoecon Outcomes Res. 2013;5:69-85. doi: 10.2147/CEOR.S39624. Epub 2013 Jan 30.

15.

Health technology assessment in Canada and the United States: the case of biologics.

Haas JS, Moskowitz EJ.

Biotechnol Healthc. 2007 Apr;4(2):47-51.

16.

Optimal decision rules for HTA under uncertainty: a wider, dynamic perspective.

Forster M, Pertile P.

Health Econ. 2013 Dec;22(12):1507-14. doi: 10.1002/hec.2893. Epub 2012 Dec 7.

PMID:
23225192
17.

Commonalities and differences in HTA outcomes: a comparative analysis of five countries and implications for coverage decisions.

Nicod E, Kanavos P.

Health Policy. 2012 Dec;108(2-3):167-77. doi: 10.1016/j.healthpol.2012.09.012. Epub 2012 Oct 22.

PMID:
23088802
18.

Early awareness and alert systems: an overview of EuroScan methods.

Gutierrez-Ibarluzea I, Simpson S, Benguria-Arrate G; Members of EuroScan International Network.

Int J Technol Assess Health Care. 2012 Jul;28(3):301-7.

PMID:
22980708
19.

Transferability of health technology assessment reports in Latin America: an exploratory survey of researchers and decision makers.

Pichon-Riviere A, Augustovski F, García Martí S, Sullivan SD, Drummond M.

Int J Technol Assess Health Care. 2012 Apr;28(2):180-6. doi: 10.1017/S0266462312000074.

PMID:
22559762
20.

Can we reliably benchmark health technology assessment organizations?

Drummond M, Neumann P, Jönsson B, Luce B, Schwartz JS, Siebert U, Sullivan SD.

Int J Technol Assess Health Care. 2012 Apr;28(2):159-65. doi: 10.1017/S0266462312000098.

PMID:
22559758
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk